ArtiaCo.

Strategy that turns clinical influence into real-world adoption

Most companies already know doctors. The challenge is understanding which relationships and conversations actually change clinical practice.

Book a Mapping Conversation

Clinicians: we secure the right industry work for you, on fair terms, with real recognition.For Clinicians

Access isn’t influence.

Smarter Clinician Engagement

What we do

We get companies working with the right clinicians, and help them earn the trust that gets their products used.

Advisory boards. Symposia. Speaker programmes. Peer-to-peer education.

The medical education you already run, built around the clinicians who genuinely shape adoption and measured to show whether practice moved.

Same tactics. Sharper return.

Behind it sits the ArC System™: Map, Plan, Build, Prove.

See the ArC System

Global Reach

Experience and networks that span the Americas, Europe and Asia Pacific.

Deep Domain Expertise

Across cataract, refractive, glaucoma, retina and dry eye. Industry and clinic.

Unrivalled Access

We’re in the rooms where opinion forms. The ArC System turns that access into adoption.

Activity Is Not Adoption

Why engagement alone doesn’t change practice

Most ophthalmology organisations run extensive clinician engagement. Yet more activity doesn’t change clinical behaviour.

The patterns are familiar: the same visible clinicians, again and again; relationships that reset between programmes; success measured by visibility, not practice. And the peer conversations that actually shape adoption never reach you.

Clinicians rarely adopt something because they saw it once. Adoption follows a path:

Observation

Respected peers use it confidently in practice.

Reinforcement

Outcomes hold up over time.

Peer validation

The experience echoes across trusted networks.

Integration

It becomes everyday clinical behaviour.

That path doesn’t happen by itself. The ArC System is how we build it. See it in practice: three case studies.

The ArC System

We find where influence sits, build on it and measure whether practice moves.

Map

Who actually moves opinion in your field, and where you stand with them.

Plan

What you need clinicians to do differently, and by when.

Build

Advocates aligned with your objectives, with contracting and compliance handled.

Prove

Quarterly scoring against the Advocacy Activity Index. Evidence decides.

See the ArC System

Proof, Not Promises

The ArC System in practice

Three recent engagements, three different briefs. The same System behind each.

Advisory Boards

Advisory boards that turn discussion into direction.

Sustainable cataract surgery: strategic direction the client could act on, and a publication-standard report.

Read the Case Study

Education Platforms

From user meeting to professional education platform.

A regional cataract and refractive meeting rebuilt around clinical need, with 600+ clinicians attending.

Read the Case Study

Launch Readiness

From market entry to clinical advocacy ecosystem.

A premium IOL market entry: 25+ KOLs engaged and four advisory initiatives executed before launch.

Read the Case Study

“Working with ArtiaCo. has been one of the most refreshing professional experiences I’ve had. Collaborative, flexible, and deeply experienced.”

Anne Nguyen Marketing Officer, Hasa Optix

Support at Every Stage

Strategic support across the product lifecycle

What shapes behaviour before launch is rarely the same as what sustains advocacy years later. We support ophthalmology organisations at the transition points where influence, perception and clinician behaviour matter most.

Pre-Launch

Identify influential clinical voices early, develop credible scientific positioning and strengthen advisory strategy.

Early influence shapes long-term perception.

Launch & Early Adoption

Clinical advocacy strategy, insight capture and interpretation, and congress and education strategy.

Early adoption depends on trusted reinforcement.

Established Brands

Advocacy and engagement continuity, emerging clinical leaders and credibility in competitive markets.

Long-term adoption depends on continued credibility.

“Ophthalmology needs more inclusive, evidence-led advocacy through fresh, diverse experts providing greater insights – moving beyond established names making predictable comments. Services that connect companies and clinicians transparently, with fair representation, will raise quality, ensure trust, and widen impact across the board, ultimately benefiting our patients.”

Professor David Lockington Consultant Ophthalmologist, Glasgow, UK

The People Behind the Work

Meet the ArtiaCo. Leadership Team

ArtiaCo.’s partners have spent their careers inside ophthalmology, medical affairs and clinician engagement. That proximity is where our understanding of influence and adoption comes from.